![Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03]()
Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03Le, Q.-T.; Harris, J.; Magliocco, A. M.; Kong, C. S.; Diaz, R.; Shin, B.; Cao, H.; Trotti, A.; Erler, J. T.; Chung, C. H.; Dicker, A.; Pajak, T. F.; Giaccia, A. J.; Ang, K. K. · Journal of Clinical Oncology · 2009